BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9003004)

  • 1. Comparative study between normal rat chromaffin and PC12 rat pheochromocytoma cells: production and effects of corticotropin-releasing hormone.
    Venihaki M; Gravanis A; Margioris AN
    Endocrinology; 1997 Feb; 138(2):698-704. PubMed ID: 9003004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PC12 rat pheochromocytoma cells synthesize dynorphin. Its secretion is modulated by nicotine and nerve growth factor.
    Margioris AN; Markogiannakis E; Makrigiannakis A; Gravanis A
    Endocrinology; 1992 Aug; 131(2):703-9. PubMed ID: 1353443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone.
    Venihaki M; Ain K; Dermitzaki E; Gravanis A; Margioris AN
    Endocrinology; 1998 Feb; 139(2):713-22. PubMed ID: 9449645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of corticotropin-releasing hormone binding protein (CRH-BP) in rat adrenals.
    Chatzaki E; Margioris AN; Gravanis A
    J Neurochem; 2002 Jan; 80(1):81-90. PubMed ID: 11796746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Markowska A; Nussdorfer GG
    Mol Cell Neurosci; 1994 Aug; 5(4):345-9. PubMed ID: 7804604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic corticotropin-releasing hormone produced by a transfected cell line chronically activates the pituitary-adrenal axis in transkaryotic rats.
    Hammer GD; Mueller G; Liu B; Petrides JS; Roos BA; Low MJ
    Endocrinology; 1992 Apr; 130(4):1975-85. PubMed ID: 1312432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuro-immuno-hormonal interactions.
    Venihaki M; Gravanis A; Margioris AN
    Ann N Y Acad Sci; 1998 May; 840():425-33. PubMed ID: 9629269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells.
    DiMaggio DA; Farah JM; Westfall TC
    Endocrinology; 1994 Feb; 134(2):719-27. PubMed ID: 8299567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxone-reversible manner.
    Venihaki M; Gravanis A; Margioris AN
    Life Sci; 1996; 58(1):75-82. PubMed ID: 8628113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nerve growth factor producing cells on anaplastic glioma and pheochromocytoma clones: involvement of other factors.
    Vinores SA; Koestner A
    J Neurosci Res; 1981; 6(3):389-401. PubMed ID: 7299847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of corticotropin-releasing hormone (CRH) on the adrenal medulla in hypophysectomized rats.
    Hoheisel G; Schauer J; Scherbaum WA; Bornstein SR
    Histol Histopathol; 1998 Jan; 13(1):81-7. PubMed ID: 9476637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro.
    Calogero AE; Burrello N; Negri-Cesi P; Papale L; Palumbo MA; Cianci A; Sanfilippo S; D'Agata R
    Endocrinology; 1996 Oct; 137(10):4161-6. PubMed ID: 8828472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells.
    Ziegler CG; Sicard F; Lattke P; Bornstein SR; Ehrhart-Bornstein M; Krug AW
    Endocrinology; 2008 Jan; 149(1):320-8. PubMed ID: 17884937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.
    Willenberg HS; Haase M; Papewalis C; Schott M; Scherbaum WA; Bornstein SR
    Neuroendocrinology; 2005; 82(5-6):274-81. PubMed ID: 16721033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid induces secretion of transforming growth factors by PC12 pheochromocytoma cells.
    Cosgaya JM; Perona R; Aranda A
    Oncogene; 1997 Feb; 14(5):579-87. PubMed ID: 9053856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion.
    Pecori Giraldi F; Cavagnini F
    J Clin Invest; 1998 Jun; 101(11):2478-84. PubMed ID: 9616219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of neurotensin content in adrenal medullary cells: comparison of PC12 cells to normal rat chromaffin cells in vitro.
    Tischler AS; Ruzicka LA; DeLellis RA
    Neuroscience; 1991; 43(2-3):671-8. PubMed ID: 1922787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.